Literature DB >> 33111749

The Brazilian National Immunization Program: 46 years of achievements and challenges.

Carla Magda Allan Santos Domingues1, Ana Goretti K Maranhão1, Antonia Maria Teixeira1, Francieli F S Fantinato1, Raissa A S Domingues2.   

Abstract

The Brazilian National Immunization Program (PNI, in Portuguese) is coordinated by the Ministry of Health in cooperation with state and municipal health departments. Since the program's creation in 1973, it has become one of the country's most relevant public health interventions, having produced important results such as certification of Brazil as free of wild poliovirus circulation, the elimination rubella virus circulation, and an important reduction in cases and deaths from vaccine-preventable diseases. Brazil is one of the countries that offers the most vaccines free of cost to the population, with 15 vaccines for children, 9 for adolescents, and 5 for adults and the elderly. The program's expansion and the maintenance of high vaccination coverage rates led to a rapid decrease in vaccine-preventable diseases, completely changing the epidemiological scenario of these diseases in Brazil in the last four decades. The country is currently witnessing an increasing share of the population without adequate vaccination. To the extent that these diseases are no longer circulating, precisely because of the high vaccination coverage rates, especially since the early 2000s, many of them are now unknown to the population. As a result, many people have no notion of the danger these diseases represent. We thus need to understand the multiple factors contributing to this decrease in coverage, which has created the risk of resurgence of serious diseases that had already been controlled or eliminated in Brazil.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33111749     DOI: 10.1590/0102-311X00222919

Source DB:  PubMed          Journal:  Cad Saude Publica        ISSN: 0102-311X            Impact factor:   1.632


  7 in total

1.  COVID-19, vaccine hesitancy and child vaccination: Challenges from Brazil.

Authors:  Michelle Fernandez; Gustavo Matta; Ester Paiva
Journal:  Lancet Reg Health Am       Date:  2022-04-01

2.  Reemergence of yellow fever virus in southeastern Brazil, 2017-2018: What sparked the spread?

Authors:  Joelle I Rosser; Karin Nielsen-Saines; Eduardo Saad; Trevon Fuller
Journal:  PLoS Negl Trop Dis       Date:  2022-02-07

3.  Social justice now for an equitable tomorrow: Reflections from the Consortium of Universities for Global Health Conference 2022.

Authors:  Beryne Odeny; Callam Davidson
Journal:  PLoS Med       Date:  2022-04-22       Impact factor: 11.069

4.  Incidence, aetiology and serotype coverage for pneumococcal vaccines of community-acquired pneumonia in adults: a population-based prospective active surveillance study in Brazil.

Authors:  Fernanda Gross Duarte; Maria Goreth Barberino; Sandra da Silva Moreira; Joice Neves Reis; Julia Regazzini Spinardi; Rodrigo Sini de Almeida; Kristen E Allen; Ronika Alexander-Parrish; Rosa Brim; César Augusto de Araújo Neto; Edson Duarte Moreira
Journal:  BMJ Open       Date:  2022-04-15       Impact factor: 3.006

5.  Understanding and addressing COVID-19 vaccine hesitancy in low and middle income countries and in people with severe mental illness: Overview and recommendations for Latin America and the Caribbean.

Authors:  Clara Gitahy Falcão Faria; Ursula Medeiros Araujo de Matos; Liana Llado-Medina; Victor Pereira-Sanchez; Rafael Freire; Antonio Egidio Nardi
Journal:  Front Psychiatry       Date:  2022-09-13       Impact factor: 5.435

6.  Is Mandatory Vaccination for COVID-19 Constitutional under Brazilian Law?

Authors:  Daniel Wei Liang Wang; Gabriela Moribe; Ana Luiza Gajardoni De M Arruda
Journal:  Health Hum Rights       Date:  2021-06

7.  The hindrances to perform the COVID-19 vaccination in Brazil.

Authors:  Matheus Negri Boschiero; Camila Vantini Capasso Palamim; Fernando Augusto Lima Marson
Journal:  Hum Vaccin Immunother       Date:  2021-08-05       Impact factor: 4.526

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.